日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Operational efficiencies of using one vs multiple bispecific antibodies for diffuse large B-cell lymphoma and follicular lymphoma in the US

在美国，使用单一双特异性抗体与多种双特异性抗体治疗弥漫性大B细胞淋巴瘤和滤泡性淋巴瘤的运营效率比较

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2636559
Graff, Tara; Bains Chawla, Savreet; Jun, Monika; Heaps, Nicole; Alshreef, Abualbishr; Tybor, David; Moore, Donald C; Zawadzki, Nadine; Spurrier, Kathryn; Shafrin, Jason
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

Pulmonary Arterial Hypertension and Cancer: Unveiling Parallels in Epidemiology, Clinical Pathways, and Therapeutic Strategies

肺动脉高压与癌症：揭示流行病学、临床路径和治疗策略的相似之处

期刊:Journal of Market Access Health Policy
影响因子:
doi:10.3390/jmahp14010009
El-Kersh, Karim; Zawadzki, Nadine; Coyle, Catelyn; Zhang, Shurui; Dalal, Dhruv; Watzker, Anna; Lautsch, Dominik; Shafrin, Jason
肺动脉高压
肿瘤
心血管
肿瘤免疫
发表日期：2026
文献求助 收藏

Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis

美国复发/难治性弥漫性大B细胞淋巴瘤患者CAR-T细胞疗法获取方面的不平等：基于SEER-Medicare数据的分析

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015634
Chung, Andrea P; Shafrin, Jason T; Vadgama, Sachin; Hurley, Kristen; Perales, Miguel-Angel; Alsfeld, Leonard C; Muthukrishnan, Sanjana; Patel, Anik R; Shah, Gunjan L; Maziarz, Richard T
B细胞
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria

一项回顾性索赔分析，旨在评估阵发性睡眠性血红蛋白尿症患者治疗期间并发症的发生率

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03001-w
Clayton, Denise; Shafrin, Jason; Yen, Glorian P; Geevarghese, Lincy; Shi, Yulin; Waheed, Anem
发表日期：2025
文献求助 收藏

Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US

美国复发/难治性弥漫性大B细胞淋巴瘤患者对双特异性抗体特性的偏好

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2572784
Mulvey, Erin; Shafrin, Jason; Than, Kyi-Sin; Muthukrishnan, Sanjana; Mutebi, Alex; Chhibber, Anindit; Wang, Anthony; Alshreef, Abualbishr; Harb, Diala; Gonzalez, Victor; Quinlan, Sarah; Patel, Vardhaman; Johnson, Patrick Connor
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Cost impact of Bruton's tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemia

布鲁顿酪氨酸激酶抑制剂选择对患有慢性淋巴细胞白血病的医疗保险患者的成本影响

期刊:Journal of Comparative Effectiveness Research
影响因子:2.5
doi:10.57264/cer-2025-0035
Kittai, Adam S; Patel, Dipen A; Shafrin, Jason; Zawadzki, Nadine; Shetty, Vikram S; Barqawi, Yazan K; Rhodes, Joanna M
白血病
信号转导
细胞生物学
发表日期：2025
文献求助 收藏

Meta-Analysis of Recurrence-Free Survival or Disease-Free Survival as a Potential Surrogate Endpoint for Overall Survival in Esophageal Cancer Trials

食管癌试验中无复发生存期或无病生存期作为总生存期潜在替代终点的荟萃分析

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.70195
Anyaduba, Uchechukwu Love; Orababa, Oluwatosin Qawiyy; Faye, Zion; Rashid, Nazia; Shafrin, Jason; Reardon, Gregory
食管癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease

索格列净与胰岛素单药治疗1型糖尿病合并慢性肾病患者的成本效益分析模型

期刊:
影响因子:
doi:10.18553/jmcp.2025.31.7.641
Kim, Jaehong; Wang, Shanshan; Marin, Moises; Sikirica, Slaven; Anderson, Mariam; Shafrin, Jason
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers

在医疗保险药品价格谈判计划中使用真实世界证据：医疗保险和医疗补助服务中心及制造商的核对清单

期刊:
影响因子:
doi:10.1093/haschl/qxaf030
Tunis, Sean R; Shafrin, Jason; Than, Kyi-Sin; Whittington, Melanie D; Willke, Richard J; Bharmal, Murtuza
发表日期：2025
文献求助 收藏

Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes: Budget impact analysis from the US payer perspective

索格列净对心力衰竭合并2型糖尿病患者的经济影响：从美国支付方的角度进行预算影响分析

期刊:
影响因子:
doi:10.18553/jmcp.2025.31.4.386
Shafrin, Jason; Wang, Shanshan; Kim, Jaehong; Sikirica, Slaven
糖尿病
心力衰竭
心血管
代谢
发表日期：2025
文献求助 收藏